REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nad-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: NAD-PHARMA Gyogyszeresz Bt. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Nad-Pharma Bt. is a company in Hungary, with a head office in Nadudvar. The enterprise currently operates in the Pharmacies and Drug Stores sector. Nad-Pharma Bt. was incorporated on November 22, 1995. 6 (2024) employees currently work for Nad-Pharma Bt.. In 2023, the company reported a net sales revenue increase of 2.16%. Its’ total assets recorded a growth of 14.78%. Nad-Pharma Bt.’s net profit margin decreased by 2.83% in 2023.

Headquarters
Fo utca 116/A. fszt. 1.
Nadudvar; Hajdu-Bihar; Postal Code: 4181

Contact Details: Purchase the Nad-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Nad-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Nad-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Nad-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Nad-Pharma Bt. report to view the information.
Incorporation Date:
November 22, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Nad-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
2.16%▲
Total operating revenue
2.22%▲
Operating profit (EBIT)
-55.42%▼
EBITDA
-52.39%▼
Net Profit (Loss) for the Period
-61.83%▼
Total assets
14.78%▲
Total equity
11.17%▲
Operating Profit Margin (ROS)
-2.88%▼
Net Profit Margin
-2.83%▼
Return on Equity (ROE)
-19.21%▼
Quick Ratio
-0.04%▼
Cash Ratio
0.04%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo